Share on LinkedInShare on LinkedIn

ARTICLE · 18 JULY 2018

MDL Court In The Testosterone Replacement Therapy Litigation Throws Out Another Large Jury Verdict

Last week, the Judge in the Testosterone Replacement Therapy (TRT) MDL threw out an over $140 million jury verdict.

United StatesLitigation, Mediation & Arbitration

This post comes solely from the Cozen O'Connor side of this blog.

Last week, the Judge in the Testosterone Replacement Therapy (TRT) MDL threw out an over $140 million jury verdict. In re Testosterone Replacement Therapy Prods. Liab. Litig. Coordinated Pretrial Proceedings, 2018 U.S. Dist. LEXIS 111724 (N.D. Ill. July 5, 2018). It wasn't the first time that the testosterone MDL court did something like that. Last December, it threw out a $150 million verdict. That's almost $300 million in verdicts total. It's got to take some strength to toss such hefty verdicts—testosterone or not.

In each instance, the court found the jury's verdict to be so internally inconsistent that it required a new trial. In the verdict tossed last week, the jury found for the defendants on a failure to warn claim based in strict liability claim but found for the plaintiff on a failure to warn claim based in negligence. That sure does seem inconsistent.

We operate a free-to-view policy, asking only that you register in order to read all of our content. Please login or register to view the rest of this article.

See more popular content from